Company Overview - Zhenghai Biological's closing price on July 8 was 20.85 yuan, up 1.21%, with a rolling PE ratio of 31.05, marking a new low in 58 days, and a total market capitalization of 3.753 billion yuan [1] - The company ranks 67th in the medical device industry, which has an average PE ratio of 51.58 and a median of 37.46 [1] Shareholder Information - As of March 31, 2025, Zhenghai Biological had 16,966 shareholders, a decrease of 193 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Business Focus - Zhenghai Biological specializes in the research, production, and sales of bio-regenerative materials, with key products including oral repair membranes, absorbable dura mater patches, bone repair materials, skin repair membranes, surgical packing sponges, self-etching adhesives, active biological bone, dura mater patches, phosphoric acid etchants, and dental pit and fissure sealants [1] Industry Recognition - The company was included in the 2023 list of leading new material enterprises in Shandong Province, recognized as one of the top 50 new material enterprises [1] Financial Performance - In the first quarter of 2025, Zhenghai Biological reported revenue of 97.42 million yuan, a year-on-year increase of 8.68%, and a net profit of 26.63 million yuan, a year-on-year decrease of 34.06%, with a gross profit margin of 80.96% [1]
正海生物收盘上涨1.21%,滚动市盈率31.05倍,总市值37.53亿元